Business Wire

  1. QIAGEN To Showcase New Sample To Insight Solutions For Complex Oncology Applications At AACR 2026 4/16/2026

    QIAGEN N.V. today announced it will showcase its oncology workflow applications at the American Association for Cancer Research (AACR) Annual Meeting 2026 in San Diego, demonstrating how its portfolio connects sample preparation with multi-omics profiling and genomic data interpretation to support cancer research and molecular diagnostics.

  2. Thermo Fisher Scientific Launches Applied Biosystems™ PowerFlex™ Thermal Cycler To Advance PCR Flexibility Productivity 4/16/2026

    Thermo Fisher Scientific Inc., the world leader in serving science, today announced the Applied Biosystems PowerFlex Thermal Cycler, a next-generation polymerase chain reaction (PCR) instrument designed to help deliver enhanced flexibility, precise thermal performance and improved productivity for modern molecular biology laboratories.

  3. Invivoscribe Announces The PrepQuant™ System, An Integrated Sample Preparation Platform That Standardizes And Streamlines Pre-Analytical Workflows 4/15/2026

    Invivoscribe, a global leader in precision diagnostics and measurable residual disease (MRD) testing, today announced the launch of the PrepQuant System, a novel sample preparation platform that integrates nucleic acid extraction, concentration, and quantification with a single automated instrument.

  4. QIAGEN Expands Into Bloodstream Infection Syndromic Testing With New Rapid QIAstat-Dx Panel 4/14/2026

    QIAGEN N.V. today announced its expansion into syndromic testing for bloodstream infections with the launch of the CE-IVDR-certified QIAstat-Dx BCID GPF Plus AMR Panel.

  5. Rune Labs Launches Parkinson's AI Companion Trained On The World's Largest Parkinson's Dataset 4/8/2026

    Today, Rune Labs announced the launch of a personalized AI companion to provide always-on support for people with Parkinson’s disease. Powered by Anthropic's Claude and built on Rune Labs' proprietary longitudinal dataset, comprising millions of hours of wearable data and FDA-cleared symptom algorithms, StrivePD Guardian continuously analyzes patients' real-time data to deliver timely, context-aware guidance on symptoms, medications, daily experiences, and care goals.

  6. Thermo Fisher Scientific Launches Thermo Scientific Glacios 3 Cryo-TEM 3/31/2026

    Thermo Fisher Scientific, the world leader in serving science, today introduces a next-generation cryogenic transmission electron microscope (cryo-TEM) designed to help scientists understand structural biology with greater clarity — now accessible in more lab environments than ever before.

  7. Ataraxis AI Launches Ataraxis Breast CTX, The First Predictive AI Test Estimating Individualized Chemotherapy Benefit In Breast Cancer 3/30/2026

    Ataraxis AI, a frontier artificial intelligence (AI) research lab developing AI-powered tools for oncology, today announced Ataraxis Breast CTX, a new predictive capability within its Ataraxis Breast platform, designed to help estimate individualized chemotherapy benefit in breast cancer patients.

  8. StarLIMS To Acquire The MODA Platform From Lonza, Expanding Deeper Into Manufacturing Operations & Quality Control 3/25/2026

    StarLIMS has agreed to acquire the MODA Platform, a trusted solution for manufacturing quality assurance and control in regulated environments. The transaction is expected to close in Q2 2026, subject to customary closing conditions.

  9. CorePlus And Ibex Expand Partnership With Clinical Deployment Of AI-Powered Diagnostics For TURP 3/25/2026

    CorePlus Servicios Clínicos y Patológicos, LLC (CorePlus), a high-complexity CLIA-certified laboratory and global leader in digital transformation, and Ibex Medical Analytics (Ibex), a pioneer in AI-powered cancer diagnostics, today announced the first clinical deployment of Ibex Prostate for Transurethral Resection of the Prostate (TURP), an AI solution for rapid, high-volume diagnostic support.

  10. Countable Labs Brings Innovative, Single-Molecule, Counting-Based PCR To European Markets With CE Mark Clearance 3/25/2026

    Countable Labs, the developer of Countable PCR, the leading PCR innovation transforming how science measures biology, achieved CE marking for its Countable 4 Platform, a single-molecule PCR instrument for molecular quantification featuring Countable PCR technology.